Anne Olson
Anne Olson's purchase track record
Anne Olson has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/8/2025 | CSR | $41K | +13.3% | +23.1% | +8.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
CareTrust REIT Holds Targets, Expands UK Deal. Analysts at RBC Capital and BMO Capital have kept their outlook on CareTrust REIT, with price targets around $43‑$45. The company has announced a $1.4 billion partnership with LNT to grow its U.K. care‑home portfolio, lifting its 2026 outlook. Meanwhile, a broader rate‑wall environment for REITs may weigh on the sector, but CareTrust’s dividend yield of 4.85% remains attractive.
Transaction History
| CSR | ▲ Buy | Option Exercise | 5,492 | $0 | 3/31/2026 | View on chart |
| CSR | ▼ Sell | Tax Withholding | 2,875 | $165K | 3/31/2026 | View on chart |
| CSR | ▲ Buy | Grant | 1,050 | $0 | 2/2/2026 | View on chart |
| CSR | ▼ Sell | Tax Withholding | 322 | $21K | 2/2/2026 | View on chart |
| CSR | ▲ Buy | Option Exercise | 1,008 | $0 | 12/26/2025 | View on chart |
| CSR | ▲ Buy | Option Exercise | 3,378 | $0 | 12/26/2025 | View on chart |
| CSR | ▲ Buy | Option Exercise | 2,938 | $0 | 12/26/2025 | View on chart |
| CSR | ▲ Buy | Grant | 8,177 | $0 | 12/26/2025 | View on chart |
| CSR | ▼ Sell | Tax Withholding | 3,835 | $258K | 12/26/2025 | View on chart |
| CSR | ▼ Sell | Tax Withholding | 4,281 | $288K | 12/26/2025 | View on chart |
| CSR | ▲ Buy | Open Market | 750 | $41K | 8/8/2025 | View on chart |
| CTRE | ▲ Buy | Grant | 5,037 | $0 | 4/29/2025 | View on chart |
| CSR | ▲ Buy | Option Exercise | 374 | $0 | 1/1/2025 | View on chart |
| CSR | ▲ Buy | Option Exercise | 1,007 | $0 | 1/1/2025 | View on chart |
| CSR | ▲ Buy | Option Exercise | 3,378 | $0 | 1/1/2025 | View on chart |
| CSR | ▼ Sell | Tax Withholding | 1,900 | $126K | 1/1/2025 | View on chart |
| CTRE | ▲ Buy | Grant | 5,428 | $0 | 4/25/2024 | View on chart |
| CSR | ▼ Sell | Tax Withholding | 921 | $54K | 1/1/2024 | View on chart |
| CSR | ▲ Buy | Option Exercise | 540 | $0 | 1/1/2024 | View on chart |
| CSR | ▲ Buy | Option Exercise | 374 | $0 | 1/1/2024 | View on chart |
| CSR | ▲ Buy | Option Exercise | 1,007 | $0 | 1/1/2024 | View on chart |
| CTRE | ▲ Buy | Grant | 6,192 | $0 | 4/27/2023 | View on chart |
| CSR | ▲ Buy | Option Exercise | 662 | $0 | 3/13/2023 | View on chart |
| CSR | ▼ Sell | Tax Withholding | 331 | $19K | 3/13/2023 | View on chart |
| CSR | ▲ Buy | Option Exercise | 540 | $0 | 1/1/2023 | View on chart |
| CSR | ▲ Buy | Option Exercise | 373 | $0 | 1/1/2023 | View on chart |
| CSR | ▼ Sell | Tax Withholding | 450 | $26K | 1/1/2023 | View on chart |
| CTRE | ▲ Buy | Grant | 6,498 | $0 | 5/3/2022 | View on chart |
| CSR | ▼ Sell | Tax Withholding | 347 | $35K | 3/13/2022 | View on chart |
| CSR | ▲ Buy | Option Exercise | 662 | $0 | 3/13/2022 | View on chart |
| CSR | ▲ Buy | Option Exercise | 560 | $0 | 3/8/2022 | View on chart |
| CSR | ▼ Sell | Tax Withholding | 293 | $30K | 3/8/2022 | View on chart |
| CSR | ▼ Sell | Tax Withholding | 3,543 | $315K | 1/27/2022 | View on chart |
| CSR | ▲ Buy | Grant | 6,712 | $0 | 1/27/2022 | View on chart |
| CSR | ▲ Buy | Option Exercise | 539 | $0 | 1/1/2022 | View on chart |
| CSR | ▼ Sell | Tax Withholding | 311 | $34K | 1/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
UBS and Piper Sandler Lower Center Price Targets
UBS and Piper Sandler both maintained Neutral ratings on Centerspace but lowered their price targets to $65 and $56, respectively. These adjustments reflect a more cautious outlook from analysts, though the stock remains supported by its 5.39% dividend yield. The average analyst target stands at $63.43, with a wide range indicating differing views on the company's future performance.
UBS and Piper Sandler Lower Center Price Targets. UBS and Piper Sandler both maintained Neutral ratings on Centerspace but lowered their price targets to $65 and $56, respectively. These adjustments reflect a more cautious outlook from analysts, though the stock remains supported by its 5.39% dividend yield. The average analyst target stands at $63.43, with a wide range indicating differing views on the company's future performance.